FDA
approval
· 2024-06-14
FDA Approved: ICATIBANT — Original Application (Alembic Pharmaceuticals Limited)
Summary
FDA approved Alembic Pharmaceuticals Limited's generic icatibant (ANDA213773) for the treatment of acute attacks of hereditary angioedema.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ICATIBANT (ICATIBANT)